Ultrasound Acute Chest Syndrome Sickle Cell Disease
Part of paid clinical trials in Indianapolis, Indiana.
- Sponsor
- Indiana University
- Study ID
- NCT06880679
- Status
- Recruiting
Conditions
- Acute Chest Syndrome
- Sickle Cell Disease
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 25 Years
- Healthy Volunteers
- Not accepted
Interventions
- Point of Care Ultrasound — DEVICEPoint of Care Ultrasound during hospitalization
Study Details
Feasibility and reliability of ultrasound in the inpatient hematology setting.
Key Dates
- Start date
- Apr 8, 2025
- Status verified
- Apr 2026
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: UltrasoundUltrasound days 1, 3, and 5 of hospitalization
Primary Outcome Measure
Participation rate [ Time Frame: Up to 5 days ]
Central Contacts
- Thomas Fisher-Heath, DO317-944-8784
- Anne Bubnick, BS317-948-0101
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Indiana University | Indianapolis | Indiana | 46202 |
Find similar trials in Indianapolis, IN
By condition
By research site
Related Studies
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruiting · American Thrombosis and Hemostasis Network · Phoenix, Arizona
- Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0Recruiting · Indiana University · Indianapolis, Indiana
- The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell DiseasePHASE3 · Recruiting · Sanofi · Birmingham, Alabama
- A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)PHASE1 · Recruiting · Disc Medicine, Inc · Birmingham, Alabama